Atezolizumab plus chemo after surgery shows benefit for stage III dMMR colon cancer
Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
Atezolizumab plus chemo after surgery shows benefit for stage III dMMR colon cancer
EBCC 2026: Radiotherapy rather than surgery may help reduce risk of lymphoedema in patients with breast cancer
EBCC 2026: Elinzanetant reduces severity and frequency of hot flushes and night sweats, regardless of type of hormone treatment breast cancer patients receive
New study reveals cellular communication driving chemotherapy resistance in pancreatic cancer
Do psychosocial factors affect cancer risk?
Researchers identify genes for predicting lung cancer recurrence
Advancing colorectal cancer care: Bringing dual immunotherapy and subcutaneous innovation to UK patients
New lipid nanoparticle design improves precision of mRNA vaccine delivery
Chronic stress and the course of cancer
EBCC 2026: Breast cancer recurrence remains low, even after ten years, with radiotherapy tailored to patient’s individual risk
EBCC 2026: Breast reconstruction using polyurethane-coated implants reduces scarring and the need for further surgery
Agent Orange linked to aggressive bone marrow cancer in Vietnam veterans